Kathy Lee-Sepsick, President & Chief Executive Officer

Kathy Lee-Sepsick, our founder, has served as our Chief Executive Officer and President and as Chairman of our board of directors since February 2004. Ms. Lee-Sepsick has served as a senior executive in the medical technologies industry for nearly three decades, compiling a successful track record in growing emerging companies and corporate operating divisions. She holds over 100 patents globally for Femasys’ products and product candidates. Ms. Lee-Sepsick was instrumental in the various stages of product and company life cycles with strategic, operational, and executive responsibilities, at start-ups Novoste Corporation, developer of intravascular therapy solution and SaluMedica, biomaterial developer of artificial cartilage. At the onset of her career, Ms. Lee-Sepsick served in a product management role at Terumo Medical Corporation, where she was integral in the management of strategic partner, Boston Scientific Corporation. Ms. Lee-Sepsick also serves on the Board of Directors of Georgia Bio. Ms. Lee-Sepsick is a graduate of Rutgers University with an MBA and a BS in Biochemistry.

Daniel Currie, Senior Vice President, Operations

Daniel Currie has served as our Senior Vice President, Operations since 2009 and previously as our Vice President, Operations since 2004. Mr. Currie has over 30 years of operational experience in the medical device industry, including assignments at early stage and large established companies. He worked closely with research and development teams, implemented and managed quality systems, spearheaded compliance and complaint handling systems at CIBA Vision Corporation. As head of Quality at Novoste Corporation, he oversaw and was directly involved in design and manufacturing controls, quality auditing (including FDA), evaluating and managing subcontractor operations, managing validation systems and performing product evaluations and testing. In addition, Mr. Currie was responsible for evaluating facilities outside the United States capable of manufacturing class III medical devices. Once the site was selected, Mr. Currie co-managed a team to establish full manufacturing operations. Mr. Currie is a graduate of Georgia Southern University with a BBA in Economics.

Lexy Kelley, MD, Vice President, Clinical and Medical Affairs

Lexy Kelley, MD has served as our Vice President, Clinical and Medical Affairs since March 2019. Dr. Kelley has over 14 years of successful leadership in clinical development and medical affairs, including global strategy development and operations for biopharmaceutical companies, such as UCB Pharma and Inhibitex from 2005 to 2011, as well as serving as medical director at Novartis in 2013. Dr. Kelley served as Senior Medical Writer at Syneos Health, a biopharmaceutical company, from January 2019 to March 2019, and as Senior Director, Scientific Affairs at PRA International, a contract research organization, from July 2011 to November 2018. Dr. Kelley has a strong background in KOL outreach and networking, advisory board management and training of clinical staff and medical science liaisons. Dr. Kelley is well published with numerous publications and abstracts and was a pathology resident at Emory University. Dr Kelley is a graduate of Southern Illinois University School of Medicine with a Doctor of Medicine and Southern Illinois University with a BA in Microbiology.

Terrell A. (Tim) Priutt, Vice President, Manufacturing

Tim Pruitt has served as our Vice President, Manufacturing, since January 2017. Mr. Pruitt has over 30 years of engineering and management experience in the medical device industry, including machine design, process development, manufacturing engineering and operations for the manufacturing and distribution of medical devices, biologics and human tissue products for life sciences companies, such as Cryolife, Aderans Research Institute, Novoste and C.R. Bard. Mr. Pruitt is a certified lean six sigma black belt and has a proven track record of improving operational efficiency, creating a culture of quality, reducing COGs and improving gross margins. Mr. Pruitt is an inventor and has six issued patents. Mr. Pruitt is a graduate of Southern Technical Institute (Kennesaw State University) with a BS in Mechanical Engineering Technology.

Gary Thompson, Vice President, Finance & Administration

Gary Thompson has served as our Vice President, Finance & Administration, since 2010. Mr. Thompson has over 30 years of finance and management experience in medical device and pharmaceutical industries, including roles at C.R. Bard, a medical technology company, and Stiefel Labs, a dermatological pharmaceutical company. Mr. Thompson previously served in units within C.R. Bard as the head of finance responsible for all budgeting, strategic plans and reporting, and has assisted in structuring corporate strategic alliance agreements with financial models and support of contract negotiation. Mr. Thompson started his career in public accounting with Deloitte Haskins and Sells, receiving his CPA while there. Mr. Thompson is a graduate of the University of Notre Dame with a BBA in Accounting.

Mary An Merchant, JD, PhD, Vice President Counsel, Intellectual Property

Mary An Merchant has served as our Vice President Counsel, Intellectual Property, since January 2018 and has overseen Femasys patent portfolio since 2004. Ms. Merchant has been practicing intellectual property law for over 25 years. She began her practice in Atlanta, Georgia, at the intellectual property boutique law firm, Jones & Askew, where she became a partner in 2000. Jones & Askew merged with Kilpatrick, Townsend & Stockton, where Ms. Merchant was a partner for several years before establishing medical device/ pharmaceutical/ biotechnology intellectual practices as a partner with Troutman Sanders, Ballard Spahr, and Morris, Manning & Martin. Ms. Merchant has published many articles on intellectual property law and a book about the America Invents Act of 2011. Currently, Ms. Merchant serves as legal counsel to Femasys Inc. and Poly-Med, Inc. Ms. Merchant is a graduate of University of Florida College of Law with a Juris Doctor Degree, the University of Florida College of Medicine with a PhD in Virology and Randolph-Macon Woman’s College with a BA in Biology.

Todd Creech, Chief Financial Advisor

Todd Creech has served as our Chief Financial Advisor since 2015. Mr. Creech is a Partner with HealthQuest Capital and has spent the last nine years as a healthcare CFO, helping build several successful companies to profitable exits. He currently serves as board member of HealthQuest portfolio companies Alcresta, BioIQ and Etairos and an observer for HealthChannels, Springbuk, and Venus Concept. He previously served as an observer for InMediata and Avedro (acquired by Glaukos). Previously, he served as CFO for ZS Pharma, Sarcode and Sirion Therapeutics. During his CFO tenure he has raised more than $500M in equity and debt, helping to build operations and companies that generated over $3.5B in exits. Earlier in his career, Mr. Creech was responsible for healthcare venture investing for Quintiles and worked with SRI International. He has also co-founded two companies; a spectroscopy platform spinout of Duke University (Centice) and a specialty pharmaceutical company (TLC Pharma). Mr. Creech is a graduate of Duke University with an MBA and Miami (Ohio) University with a BA in Finance and Accounting.

Jeffery Marcus, MS, MD, Chief Medical Advisor

Jeffrey Marcus, MD has served as our Chief Medical Advisor since 2004. Dr. Marcus has been a practicing Gynecologist/ Obstetrician for over 25 years. Dr. Marcus joined North Atlanta Women's Specialists when it was formed in 1994, and his special interests include management of high-risk pregnancies, minimally invasive gynecologic surgery, contraception, and menopause care. Dr. Marcus is board certified and a fellow of the American College of Obstetricians and Gynecologists. Dr. Marcus is a member of the American Association of Gynecologic Laparoscopists and the Society for Family Planning. In addition, Dr. Marcus is on the executive committee of the Atlanta Women’s Health Group and previously served as Chairman of Perinatal Services at Northside Hospital in Atlanta. Dr Marcus is a graduate of The George Washington University with a Doctor of Medicine and a MS in Biomedical Engineering and Dickinson College with a BS in Physics.